VACCINE

The invention provides a recombinant polypeptide comprising: i) a dendroaspin scaffold; and ii) a first non-dendroaspin amino acid sequence wherein said first non-dendroaspin amino acid sequence comprises a first epitope capable of eliciting an immune response against a zoonotic pathogen protein..

Medienart:

Patent

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Europäisches Patentamt - (2022) vom: 03. März Zur Gesamtaufnahme - year:2022

Sprache:

Englisch

Beteiligte Personen:

KAKKAR AJAY [VerfasserIn]
LU XINJIE [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

615
A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d)
C07K: Peptides (peptides containing β-lactam rings c07d;cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, c07d;ergot alkaloids of the cyclic peptide type c07d0519020000; single cell proteins, enzymes c12n;genetic engineering processes for obtaining peptides c12n0015000000)
Che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2022-03-03, Last update posted on www.tib.eu: 2022-08-02, Last updated: 2023-02-09

Patentnummer:

WO2022043686

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA012871915